Denileukin Diftitox (Ontak) as Maintenance Therapy for Peripheral T-Cell Lymphomas: Three Cases with Sustained Remission

<div>Case 1: CTs of the abdomen illustrating (a) subcutaneous nodules prior to initiation of denileukin diftitox and (b) resolution of the subcutaneous nodules after treatment with denileukin diftitox.</div>

Case Reports in Oncological Medicine

fig1

Figure 1

Figure 1: Denileukin Diftitox (Ontak) as Maintenance Therapy for Peripheral T-Cell Lymphomas: Three Cases with Sustained Remission 